Cargando…

Therapy-related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy

Detalles Bibliográficos
Autores principales:	Laribi, Kamel, Baugier de Materre, Alix, Ghez, David, Dartigeas, Caroline, Tomowiak, Cécile, Mahé, Béatrice, Micol, Jean-Baptiste, Merabet, Fatiha, Leprêtre, Stéphane, Herbaux, Charles, Ysebaert, Loïc, Le Calloch, Ronan, Willems, Lise, Voldoire, Maud, Roos-Weil, Damien, Bravetti, Clotilde, Touileb, Yamina, Davi, Frédéric, Nguyen-Khac, Florence, Maloum, Karim, Béné, Marie C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208889/ https://www.ncbi.nlm.nih.gov/pubmed/35747848 http://dx.doi.org/10.1097/HS9.0000000000000716

Ejemplares similares

Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma
por: Laribi, Kamel, et al.
Publicado: (2022)

Advances in the understanding and management of T-cell prolymphocytic leukemia
por: Laribi, Kamel, et al.
Publicado: (2017)

Humoral Response to mRNA Vaccines BNT162b2 and mRNA-1273 COVID-19 in Chronic Lymphocytic Leukemia Patients
por: Bagacean, Cristina, et al.
Publicado: (2021)

Quadri‐lineage disease involving nodal B‐cell marginal zone lymphoma, high‐grade B‐cell lymphoma, Kaposi's syndrome, and acute myeloid leukemia
por: Laribi, Kamel, et al.
Publicado: (2015)

Impact of the relative dose intensity on survival of patients with high‐risk myelodysplastic syndromes treated with Azacitidine
por: Laribi, Kamel, et al.
Publicado: (2019)

Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Recommendations of the French CLL Study Group (FILO)
por: Quinquenel, Anne, et al.
Publicado: (2020)

P650: EFFECTIVENESS OF VENETOCLAX ACCORDING TO THE CHARACTERISTICS OF PATIENTS WITH CLL IN MONOTHERAPY AND COMBINATION WITH RITUXIMAB. INTERIM ANALYSIS OF REAL-LIFE DATA FROM VERONE STUDY
por: Ysebaert, Loïc, et al.
Publicado: (2023)

Unidimensional scales for fears of cancer recurrence and their psychometric properties: the FCR4 and FCR7
por: Humphris, G. M., et al.
Publicado: (2018)

Humoral response to mRNA anti–COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia
por: Bagacean, Cristina, et al.
Publicado: (2022)

Human FcR Polymorphism and Disease
por: Li, Xinrui, et al.
Publicado: (2014)

Anti-human CD40 monoclonal antibody therapy is potent without FcR crosslinking
por: Richman, Lee P, et al.
Publicado: (2014)

A fixed-duration immunochemotherapy approach in CLL: 5.5-year results from the phase 2 ICLL-07 FILO trial
por: Michallet, Anne-Sophie, et al.
Publicado: (2023)

Telomere length predicts for outcome to FCR chemotherapy in CLL
por: Norris, Kevin, et al.
Publicado: (2019)

Interpretation of normal anatomic structures on chest radiography: Comparison of Fuji Computed Radiography (FCR) 5501D with FCR 5000 and screen‐film system
por: Nakashima, Kazuaki, et al.
Publicado: (2003)

Blocking of FcR Suppresses the Intestinal Invasion of Scrapie Agents
por: Uraki, Ryuta, et al.
Publicado: (2011)

A phase 1b/2 study of duvelisib in combination with FCR (DFCR) for frontline therapy for younger CLL patients
por: Davids, Matthew S., et al.
Publicado: (2020)

PB1875: TREATMENT OF YOUNGER PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN TUNISIA: FCR STILL STANDARD FOR FIRST-LINE THERAPY
por: Miled, W., et al.
Publicado: (2022)

Cognitive behavioral therapy for reducing fear of cancer recurrence (FCR) among breast cancer survivors: a systematic review of the literature
por: Park, So-Young, et al.
Publicado: (2022)

Does early disease progression predict survival after first line‐treatment of Waldenström macroglobulinemia?
por: Labreuche, Julien, et al.
Publicado: (2022)

Meningeal involvement in multiple myeloma
por: Laribi, Kamel, et al.
Publicado: (2015)

T cell receptor-independent CD2 signal transduction in FcR+ cells
Publicado: (1991)

Phospholipid Scramblase 1 Modulates FcR-Mediated Phagocytosis in Differentiated Macrophages
por: Herate, Cecile, et al.
Publicado: (2016)

Insulin-regulated aminopeptidase contributes to setting the intensity of FcR-mediated inflammation
por: Bratti, Manuela, et al.
Publicado: (2022)

Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group
por: Aubrais, Raphaelle, et al.
Publicado: (2022)

Decreased NK Cell FcRγ in HIV-1 Infected Individuals Receiving Combination Antiretroviral Therapy: a Cross Sectional Study
por: Leeansyah, Edwin, et al.
Publicado: (2010)

Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine
por: Boudreau, Carolyn M., et al.
Publicado: (2019)

Secondary malignancies and survival of FCR‐treated patients with chronic lymphocytic leukemia in Central Europe
por: Kósa, Fruzsina, et al.
Publicado: (2022)

Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B cells and FcγRIIIa polymorphism. A study of FCGCLL/WM and GOELAMS groups
por: Gagez, A-L, et al.
Publicado: (2016)

The Xenopus FcR family demonstrates continually high diversification of paired receptors in vertebrate evolution
por: Guselnikov, Sergey V, et al.
Publicado: (2008)

Rervised cost estimte for a set of intersecting storage rings (ISR) FCR the CERN-PS
por: Zilverschoon, C J
Publicado: (1963)

FcRγ Controls the Fas-Dependent Regulatory Function of Lymphoproliferative Double Negative T Cells
por: Juvet, Stephen C., et al.
Publicado: (2013)

The Human FcγRII (CD32) Family of Leukocyte FcR in Health and Disease
por: Anania, Jessica C., et al.
Publicado: (2019)

The Diverse Functions of the Ubiquitous Fcγ Receptors and Their Unique Constituent, FcRγ Subunit
por: Hamdan, Thamer A., et al.
Publicado: (2020)

Long Term Follow-up Data and Health-Related Quality of Life in Frontline Therapy of Fit Patients Treated With FCR Versus BR (CLL10 Trial of the GCLLSG)
por: Kutsch, Nadine, et al.
Publicado: (2020)

Retrospective analysis of a cohort of 41 de novo B-cell prolymphocytic leukemia patients: impact of genetics and targeted therapies (a FILO study)
por: Algrin, Caroline, et al.
Publicado: (2022)

CD16 (FcRγIII) as a potential marker of osteoclast precursors in psoriatic arthritis
por: Chiu, Yahui Grace, et al.
Publicado: (2010)

A qualitative exploration of fear of cancer recurrence (FCR) amongst Australian and Canadian breast cancer survivors
por: Thewes, B., et al.
Publicado: (2015)

Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL): a randomized phase 3 trial
por: Herling, Carmen D., et al.
Publicado: (2020)

The Value of Neutrophil Gelatinase-Associated Lipocalin Receptor as a Novel Partner of CD38 in Chronic Lymphocytic Leukemia: From an Adverse Prognostic Factor to a Potential Pharmacological Target?
por: Bauvois, Brigitte, et al.
Publicado: (2023)

Genome-wide association and selective sweep analyses reveal genetic loci for FCR of egg production traits in ducks
por: Liu, Hehe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l3ophcajkp71r8e805jqpuae5u